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MAN1 (also known as LEMD3) is an integral protein of the inner nuclear membrane. Recently, mutations in
MAN1 have been shown to result in osteopoikilosis, Buschke–Ollendorff syndrome and melorheostosis. We
show that the nucleoplasmic, C-terminal domain of human MAN1 binds to Smad2 and Smad3 and antagonizes
signaling by transforming growth factor-b (TGF-b). In a yeast two-hybrid screen using the C-terminal domain of
MAN1 as bait, eight positive clones were obtained that encoded Smad3. In direct two-hybrid assays, this
portion of MAN1 bound to Smad2 and Smad3. In glutathione-S-transferase precipitation assays, the C-terminal
domain of MAN1 bound to Smad2 and Smad3 under stringent conditions. Antibodies against MAN1 were able
to co-immunoprecipiate Smad2 from cells, demonstrating that they reside in the same complex in vivo. TGF-b
treatment stimulated transcription from a reporter gene in control cells, but reporter gene stimulation was
significantly inhibited in cells overexpressing MAN1 or its C-terminal domain but not its N-terminal domain.
TGF-b-induced cell proliferation arrest was also inhibited in stable cell lines overexpressing MAN1. These
results show that the nuclear envelope regulates a signal transduction pathway and have implications for
how mutations in nuclear envelope proteins cause different human diseases.
INTRODUCTION
The nuclear envelope, including the nuclear lamins and inte-
gral proteins of the inner nuclear membrane, may function
in the regulation of gene expression (1–9). This could have
pathophysiological implications for the recent discoveries
that a growing number of inherited diseases are caused by
mutations in inner nuclear membrane proteins (2–9). Putative
gene regulatory functions of inner nuclear membrane proteins
have been inferred primarily from their interactions with DNA
and proteins that function in gene regulation. For example,
lamins A and C bind to DNA and histones (10–13) and
retinoblastoma protein (14). The inner nuclear membrane
protein LBR binds to mammalian orthologs of Drosophila het-
erochromatin protein 1 (15,16) and DNA (17,18). Emerin and
lamina-associated polypeptide 2-b bind to the transcriptional
repressor germ cell-less (19,20). Despite these observations,
however, there are few actual demonstrations that nuclear
envelope proteins modulate gene regulation by interacting
with transcription factors.
MAN1 (also known as LEMD3) is an integral protein of
the inner nuclear membrane with a nucleoplasmic N-terminal
domain, two transmembrane segments and a C-terminal
domain (21). The N-terminal, nucleoplasmic domain contains
a LEM domain, a small helix-turn-helix motif also present in
emerin, lamin-associated polypeptide 2 and several other pro-
teins (21–23). The C-terminal domain of MAN1 following
the second transmembrane segment also faces the nucleo-
plasm (21). We now show that this domain of human MAN1
interacts with Smad2 and Smad3 and antagonizes signaling
by transforming growth factor-b (TGF-b). Very recently,
Hellemans et al. (24) also showed that loss-of-function
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mutations in MAN1 result in osteopoikilosis, Buschke–
Ollendorff syndrome and melorheostosis and that these
mutations are associated with enhanced TGF-b activity.
RESULTS
MAN1 binds to Smad2 and Smad3
We performed a yeast two-hybrid screen of 10 000 000
recombinants in a human skeletal muscle cDNA library using
the nucleoplasmic, C-terminal domain of MAN1 as bait. The
screen yielded eight positive clones that encoded portions of
or full-length Smad3. To determine whether the C-terminal
domain of MAN1 bound to other Smad proteins and which
domains of the proteins mediate their interactions, we per-
formed direct yeast two-hybrid assays. In this assay, the C-term-
inal domain of MAN1 interacted with Smad2 and Smad3, but
not with Smad1 or Smad4 (Fig. 1A). The MH2 domains
mediated the binding of these Smads to MAN1 (Fig. 1A).
The smallest portion of MAN1 that could bind to Smad2 and
Smad3 was from amino acid 730 to amino acid 910
(Fig. 1B). A RNA recognition motif, between amino acid resi-
dues 801 and 857 of MAN1, appears to be necessary but not
sufficient for binding, as the polypeptide from amino acid 776
to amino acid 910, which contains this motif, did not bind.
To confirm the interactions between the C-terminal domain
of MAN1 and Smad2 and Smad3 observed in the yeast two-
hybrid assay, we performed glutathione-S-transferase (GST)
precipitation assays. In these assays, [35S]-labeled C-terminal
domain of MAN1, synthesized by in vitro transcription–trans-
lation, was incubated with GST fusions of Smad2 and Smad3.
The C-terminal domain of MAN1 bound to Smad2 and Smad3
under stringent conditions including 1% Nonident P-40 or
1.0 M NaCl (Fig. 2). Binding between the MH2 domains of
Smad2 and Smad3 and the C-terminal domain of MAN1
was also confirmed in GST precipitation experiments (data
not shown).
Co-immunoprecipitation of Smad2 with
anti-MAN1 antibodies
To determine whether MAN1 and Smad2 or Smad3 reside in
the same complex in vivo at endogenous cellular levels, we
performed co-immunoprecipitation. Immunization of four
rabbits with MAN1 fusion proteins or synthetic MAN1
polypeptides did not yield antibodies that were suitable for
immunoblotting or immunoprecipitation (data not shown).
However, we were able to use MAN antiserum (25) to immu-
noprecipitate MAN1. This well-characterized human serum
contains high-titer autoantibodies against MAN1, lamina-
associated polypeptide-2-b and an unidentified protein with
a molecular mass of 35 kDa (21,25,26). As a control, we
used serum from a human subject with primary biliary cirrho-
sis, which contains autoantibodies against the E2-subunit of
mitochondrial pyruvate dehydrogenase (27).
Immunoblotting of proteins separated by SDS–polyacryl-
amide gel electrophoresis showed that HeLa cell lysates
contained MAN1, Smad2 and b-tubulin (Fig. 3A). As
expected (21,25,26), MAN1 antiserum also recognized
lamina-associated polypeptide-2-b (58 kDa) and a lower
molecular mass protein (35 kDa). The lysates, in buffer con-
taining weak detergent to solubilize membrane proteins, were
incubated with protein A-coupled beads to which antibodies in
either MAN antiserum or control serum had been cross-linked.
Beads were then extensively washed and bound proteins
eluted by boiling in SDS sample buffer. Immunoblotting of
proteins retained on the beads coupled to anti-MAN1 anti-
bodies showed that MAN1 and Smad2, but not b-tubulin,
bound to beads (Fig. 3B). In contrast, MAN1, Smad2 or
b-tubulin bound to beads to which control antibodies in
serum from a subject with primary biliary cirrhosis had been
coupled (Fig. 3C). The E2-subunit of pyruvate dehydrogenase
Figure 1. Domain-specific interactions between the C-terminal domain of
MAN1 and the Smads in the yeast two-hybrid assay. (A) Smad1, Smad2
and Smad3 are divided into three domains, MH1, linker and MH2, as indicated
schematically at the top of the diagram. In the yeast two-hybrid assay, the
C-terminal domain of MAN1 interacted with full-length (FL) Smad2 and
Smad3, but not with Smad1 or Smad4. The MH2 domains of Smad2 and
Smad3 interacted with MAN1; the MH1 and linker domains did not. (B)
Various portions of the MAN1 C-terminal domain were tested for their inter-
actions with Smad2 and Smad3 in the yeast two-hybrid assay. Corresponding
amino acid residues of full-length MAN1 are indicated at the left in the
diagram. Portions of the MAN1 C-terminal domain from amino acid 680 to
amino acid 910 and from amino acid 730 to amino acid 910 interacted with
Smad2 and Smad3. Each direct two-hybrid experiment was performed three
times; plus indicates three out of three experiments were positive for an inter-
action and minus indicates three out of three were negative for an interaction.
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did bind to these beads (data not shown). Unfortunately, two
different commercially available antibodies against Smad3
were not of high enough quality to clearly detect this protein
in cell lysates or immunoprecipitates. The anti-Smad2 and
anti-Smad3 antibodies also could not immunoprecipitate
their recognized antigens under the conditions used. Nonethe-
less, these results demonstrate that MAN1 and Smad2, at their
endogenous levels in cells, are co-immunoprecipitated by anti-
MAN1 antibodies.
MAN1 antagonizes transcriptional activation by TGF-b
Smad2 and Smad3 are intracellular mediators of signaling by
TGF-b and other TGF-b superfamily members such as
inhibin, activin and nodal (28–30). In the basal state, Smad2
and Smad3 are primarily cytoplasmic and translocated to the
nucleus after phosphorylation by activated cell surface recep-
tors for TGF-b or other ligands. In the nucleus, Smad2 and
Smad3 interact with Smad4 and other co-factors to form a
complex that regulates transcription from approximately 500
target genes. We therefore examined whether MAN1 affects
TGF-b-activated transcription. HepG2 cells were transiently
transfected to overexpress MAN1, its C-terminal nucleoplas-
mic domain or its N-terminal nucleoplasmic domain. HepG2
expressed endogenous MAN1 (Fig. 4A), and transfected
cells expressed the appropriate plasmid-encoded proteins
(Fig. 4B). Cells were co-transfected with reporter plasmid
p3TP-LUX, which contains a TGF-b-activated plasminogen
activator inhibitor-1 promoter that drives luciferase expression
(31). Treatment of cells with TGF-b stimulated transcription
from the reporter gene in control cells transfected with
‘empty’ vector and those overexpressing the N-terminal
domain of MAN1, which does not bind to Smad2 or Smad3
(Fig. 4C). TGF-b stimulation of the reporter gene was signifi-
cantly inhibited in cells overexpressing the C-terminal domain
of MAN1 and full-length MAN1 (Fig. 4C). Although the
results were less dramatic than that observed in HepG2
cells, p3TP-LUX reporter activity was also stimulated by
200 pM TGF-b in Mv1Lu cells transfected with ‘empty’
vector (28.3+ 0.98-fold; mean+ standard error) and the
stimulation was inhibited in Mv1Lu cells transiently trans-
fected to overexpress MAN1 (21.2+ 0.90-fold; P , 0.05,
n ¼ 2). These results show that MAN1 antagonizes TGF-b
activation of transcription mediated by the transcription
factors Smad2 and Smad3.
MAN1 antagonizes TGF-b-induced cell
proliferation arrest
TGF-b blocks the proliferation of mink lung epithelial cell
line Mv1Lu (32,33). To examine the effects of MAN1 on inhi-
bition of Mv1Lu cell proliferation by TGF-b, we established
stable transfected cell lines that overexpress FLAG epitope-
tagged full-length MAN1. These cell lines expressed MAN1
Figure 2. Binding of the C-terminal domain of MAN1 to Smad2 and Smad3 in
GST precipitation assays. GST-fusions of Smad2 and Smad3 were incubated
with 35[S]-labeled C-terminal domain of MAN1 in buffers of increasing
NaCl and detergent concentrations. GST-fusion proteins were precipitated
using glutathione–Sepharose and, after washing with buffer, the bound pro-
teins were stripped with SDS and analyzed by autoradiography of SDS–poly-
acrylamide slab gels. Upper panel shows autoradiogram from experiment with
GST–Smad2 and lower panel with GST–Smad3. Migrations of molecular
mass standards (kDa) are indicated at the left of the panels. First lanes show
10% of the 35[S]-labeled MAN1 C-terminal domain used in each binding reac-
tion. Lanes labeled ‘Beads’ and ‘GST’ show lack of binding of C-terminal
MAN1 to glutathione–Sepharose alone or coupled to only GST. Lanes
labeled ‘NP-40%’ show binding to GST–Smad2 and GST–Smad3 in the pre-
sence of increasing concentrations of Nonident P-40. Lanes labeled ‘NaCl (M)’
show binding to GST–Smad2 and GST–Smad3 in increasing molar concen-
trations of NaCl. Representative autoradiograms shown are from one of
three separate experiments.
Figure 3. Co-immunoprecipitation showing that MAN1 and Smad2 interact in
vivo at endogenous levels. (A) Immunoblots showing that HeLa cell lysates
used for co-immunoprecipitation contained MAN1, Smad2 and b-tubulin. Pro-
teins in cell lysates were separated by SDS–polyacrylamide gel electrophor-
esis, transferred to nitrocellulose strips and probed with MAN antiserum
(lane 1, MAN), anti-Smad2 antibodies (lane 2, Smad2) or anti-b-tubulin anti-
bodies (lane 3, tubulin). In addition to recognizing MAN1, MAN antiserum
also recognized lamina-associated polypeptide-b-2 (58 kDa) and a lower
molecular mass protein (35 kDa). Proteins recognized are indicated at the
right and migrations of molecular mass standards are indicated at the left.
(B) Immunoblots showing that MAN1 and Smad2 are co-immunoprecipitated
from HeLa cell lystates. Cell lysates were passed over protein A-coupled
beads to which antibodies in MAN antiserum had been cross-linked. Beads
were extensively washed and bound proteins eluted by boiling in SDS
sample buffer. Proteins eluted from beads with SDS were separated by
SDS–polyacrylamide gel electrophoresis, transferred to nitrocellulose strips
and probed with MAN antiserum (lane 1, MAN), anti-Smad2 antibodies
(lane 2, Smad2) or anti-b-tubulin antibodies (lane 3, tubulin). Proteins recog-
nized are indicated at the right and migrations of molecular mass standards are
indicated at the left. (C) Immunoblots showing that MAN1, Smad2 and
b-tubulin were not precipitated by control antibodies. Cell lysates were
passed over protein A-coupled beads to which antibodies in serum from a
subject with primary biliary cirrhosis had been cross-linked. Beads were
extensively washed and bound proteins eluted by boiling in SDS sample
buffer. Proteins eluted from beads with SDS were separated by SDS–
polyacrylamide gel electrophoresis, transferred to nitrocellulose strips and
probed with MAN antiserum (lane 1, MAN), anti-Smad2 antibodies (lane 2,
Smad2) or anti-b-tubulin antibodies (lane 3, tubulin). Migrations of molecular
mass standards are indicated at the left.
Human Molecular Genetics, 2005, Vol. 14, No. 3 439
D
ow
nloaded from
 https://academ
ic.oup.com
/hm
g/article-abstract/14/3/437/746556 by U
niversity of C
alifornia, R
iverside user on 23 July 2019
at the nuclear envelope (Fig. 5A), but cellular levels of Smad2
were not altered (Fig. 5B).
We treated native Mv1Lu cells and Mv1Lu cell lines over-
expressing MAN1 with TGF-b. Proliferation of native Mv1Lu
cells is inhibited by TGF-b in a concentration-dependent
manner, with .50% inhibition of growth at 200 pM (Fig. 6).
In contrast, proliferation of two Mv1Lu lines that stably over-
expressed MAN1 was not significantly inhibited by TGF-b
(Fig. 6).
DISCUSSION
The present results demonstrate that the inner nuclear mem-
brane protein MAN1 is a negative regulator of Smad2 and
Smad3. MAN1 can bind to Smad2 and Smad3, potentially
sequester them at the inner nuclear membrane and compete
with other Smad-binding proteins for the formation of a
transcription activation complex (Fig. 7). Other negative reg-
ulators of Smad transcriptional function include c-Ski
(34,35), SnoN (36) and Evi-1 (37), which bind directly to
Smad proteins. Some of these negative regulators of Smads
function by competitive binding that prevents formation of
an active transcriptional complex (29,30,38).
Recent reports have shown that two other LEM domain-
containing proteins in Xenopus bind to Smad1 and antagonize
bone morphogenetic protein signaling (39,40). One of these
proteins appears to be the Xenopus ortholog of MAN1 in
the inner nuclear membrane (39). The other, called SANE,
lacks the inner nuclear membrane targeting sequences of
Figure 4. Overexpression of MAN1 inhibits TGF-b stimulated transcription of a plasminogen activator inhibitor-1 promoter-containing reporter gene p3TP-
LUX. (A) Immunoblot showing that HepG2 cells express endogenous MAN1. Proteins in HepG2 cell lysates were separated by SDS–polyacrylamide electro-
phoresis, transferred to nitrocellulose strips and probed with MAN antiserum, which recognizes MAN1, lamina-associated polypeptide-2-b and an unidentified
protein with an apparent molecular mass of 35 kDa. Migration of MAN1 is indicated at right and migrations of molecular mass standards are indicated at left.
(B) Immunofluorescence micrographs showing that HepG2 cells expressed FLAG-tagged proteins encoded by transfected plasmids. Transfected HepG2 cells
were labeled with mouse anti-FLAG antibodies (top panels, FLAG), rabbit anti-lamin B1 antibodies (bottom panels, lamin B1) and appropriate secondary flu-
orescent antibodies. Cells were transfected with ‘empty’ vector (Vector) or plasmids that expressed FLAG-tagged C-terminal domain of MAN1 (CT-MAN1),
N-terminal domain of MAN1 (NT-MAN1) and full-length MAN1 (FL-MAN1). Bar: 10 mm. (C) Luciferase reporter gene activities in transfected HepG2 cells.
Cells were co-transfected with p3TP-LUX, pSV-b-galactosidase and either ‘empty’ vector (white rectangles) or plasmids that expressed the C-terminal domain
of MAN1 (black rectangles), the N-terminal domain of MAN1 (diagonal striped rectangles) or full-length MAN1 (spotted rectangles). Cells were treated with
TGF-b for 24 h and relative luciferase activities measured in extracts and normalized to b-galactosidase activities. Activities (relative luciferase activity) are
shown on the y-axis. Activities in the absence of TGF-b are shown at the left (2), after treatment with 80 pM TGF-b at the center (80) and after treatment
with 200 pM TGF-b at the right (200). Values are means for n ¼ 3 experiments (in which each sample was analyzed in triplicate); bars indicate standard
errors. Stimulation of luciferase activities with 80 and 200 pM of TGF-b was significantly inhibited (P, 0.01) in cells overexpressing the C-terminal
domain of MAN1 and full-length MAN1.
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MAN1 identified by Wu et al. (41) and is likely associated
with the plasma membrane (40). Although there are structural
similarities between Smad1, Smad2 and Smad3, it is intri-
guing that, in amphibians, the same domain of MAN1 that
we have shown binds to Smad2 and Smad3 in mammals
appears to bind more strongly to Smad1. However, both
Osada et al. (39) and Raju et al. (40) reported that Xenopus
MAN1 and SANE bind ‘weakly’ to Smad2 or Smad3. It is
likely that human MAN1 also binds to Smad1 (24);
however, for various reasons, the interaction may not have
been detected in the assays we used in the current study.
These previous reports (24,39,40) and our current results
suggest that depending upon the species and possibly other
factors, MAN1-like proteins differentially regulate signaling
by TGF-b, bone morphogenic protein and possibly other
TGF-b superfamily members.
After the experimental work described in this paper was
completed, Hellemans et al. (24) reported that osteopoikilosis,
Buschke–Ollendorff syndrome and melorheostosis are allelic
variants caused by loss-of-function mutations in MAN1.
These investigators also showed that MAN1 interacted with
Smad1 and Smad2 in the yeast two-hybrid assay and reported
that MAN1 overexpression inhibits TGF-b and BMP activation
of gene expression (24). Fibroblasts from subjects with these
disorders also showed enhanced expression of a TGF-b
responsive gene (24). Osteopoikilosis is an autosomal domi-
nant skeletal dysplasia characterized by multiple hyperostotic
areas in different parts of the skeleton and can occur either as
an isolated anomaly or in association with other abnormalities
of skin and bone (42,43). Buschke–Ollendorff syndrome is an
autosomal dominant disorder with the association of osteopoi-
kilosis with disseminated connective-tissue nevi (44,45).
Melorheostosis is characterized by hyperostosis of tubular
bone cortex and is often accompanied by abnormalities of
adjacent soft tissues such as joint contractures, scleroderma-
tous skin lesions, muscle atrophy and hemangiomas (46,47).
Differences in the relative degrees of enhanced TGF-b and
bone morphogenic protein signaling can explain most or all
of these phenotypes.
In addition to bone and skin, signaling by TGF-b super-
family proteins controls specification of developmental state
during embryogenesis and in a wide variety of mature
tissues (29). In recent years, mutations in the inner nuclear
membrane proteins lamins A and C have been linked to a
wide range of inherited diseases including autosomal domi-
nant Emery–Dreifuss and other muscular dystrophies,
Dunnigan-type partial lipodystrophy, Charcot–Marie–Tooth
type 2 peripheral neuropathy, madibuloacral dysplasia and
Hutchinson–Gilford progeria syndrome (reviewed in 2–9).
MAN1 is associated with the nuclear lamina (25) and
nuclear lamins bind to emerin (48–50). These findings
suggest the presence of an interconnected network of
Figure 5. Immunofluorescence micrograph showing expression of FLAG-
tagged MAN1 at the nuclear envelope in stably transfected Mv1Lu cells
and no change in the cellular levels of Smad2. (A) A stably transfeced
Mv1Lu cells expressing MAN1 with a FLAG-epitope at the N-terminal.
Cells were fixed and analyzed by immunofluorescence microscopy using
mouse anti-FLAG antibodies and fluorescein-isothiocyanate conjugated
rabbit anti-mouse secondary antibodies. Bar: 10 mm. (B) Immunoblot
showing no change in levels of Smad2 in control Mv1Lu cells and those
shown in (A) that express MAN1. Proteins in Mv1Lu cell lysates were separ-
ated by SDS–polyacrylamide electrophoresis, transferred to nitrocellulose
strips and probed with antibodies that recognize Smad2 (top panel, Smad 2)
and b-tubulin (bottom panel, tubulin). Lane 1 shows proteins from untrans-
fected Mv1Lu cells and lanes 2 and 3 show proteins from two different
Mv1Lu cells stably transfected to overexpress MAN1 and used in the exper-
iments in Figure 6. Migrations of molecular mass standards are indicated at
left.
Figure 6. MAN1 inhibition of Mv1Lu cell proliferation arrest by TGF-b. Two
Mv1Lu cells lines that stably overexpress MAN1 (rectangles and triangles)
were treated with increasing concentrations of TGF-b (x-axis). Cell prolifer-
ation was measured and plotted as percent of growth inhibition compared to
proliferation in the absence of TGF-b (y-axis). Similar data for untransfected
Mv1Lu cells are shown for comparison (black diamonds). Results shown are
means for cells grown in three separate wells on two different days for each
condition (n ¼ 6).
Human Molecular Genetics, 2005, Vol. 14, No. 3 441
D
ow
nloaded from
 https://academ
ic.oup.com
/hm
g/article-abstract/14/3/437/746556 by U
niversity of C
alifornia, R
iverside user on 23 July 2019
MAN1, lamins and emerin at the inner nuclear membrane
(Fig. 7). As MAN1 is a regulator of signaling by the TGF-b
superfamily of cytokines and has physical connections to
lamins and overlapping functions with emerin (25,51), it is
possible that mutations in lamins A and C and emerin cause
diseases by altering MAN1 function in certain cell types.
This could lead to tissue-specific alterations in signaling by
TGF-b superfamily members. Notably, myostatin, a TGF-b
superfamily member, signals via Smad2 and Smad3 and
decreases skeletal muscle mass by inhibiting myoblast pro-
liferation and differentiation (52–54). Loss of MAN1 function
at the inner nuclear membrane in striated muscle could there-
fore lead to an enhancement in myostatin signaling. This
hypothesis warrants testing in X-linked Emery–Dreifuss mus-
cular dystrophy, which is caused by mutations in emerin (55),
and autosomal dominant Emery–Dreifuss muscular dystrophy
and limb girdle muscular dystrophy type 1 B, which are
caused by mutations in lamins A and C (56,57).
MATERIALS AND METHODS
Yeast two-hybrid screening and assays
Human skeletal muscle pre-transformed Matchmaker cDNA
library (HY4047AH; Clontech) was screened according to
the manufacturer’s instructions using the C-terminal domain
of MAN1 as bait. To construct the bait plasmid, DNA encod-
ing amino acid 681 to amino acid 911 of MAN1 was amplified
by polymerase chain reaction using MAN1 full-length cDNA
(21) as template. Amplified DNA was cloned in-frame into the
GAL4 DNA binding domain fusion vector pGBKT7 (Clon-
tech) to yield pGBKT7-MAN1-CT. Saccharomyces cerevisiae
strain AH109 was transformed with this bait plasmid, and the
library recombinants in the GAL4 activation domain fusion
vector pACT2 were pre-transformed in yeast host strain
Y187. Before two-hybrid library screening using yeast
mating, the optimal concentration of 3-aminotriazole was
tittered to eliminate background selection, and the phenotypes
and mating efficiencies were checked by controls. Positive
pACT2-derived plasmids were rescued and used to co-trans-
form yeast with pGBKT7-53 (Clontech) and pGBKT7 to
confirm the specificities of the reactions. DNA inserts of posi-
tive clones obtained from library screening and the DNA
insert of pGBKT7-MAN1-CT were also excised and cloned
into pGBKT7 and pACT2, respectively, for co-transformation
and mating assays to further confirm the interactions. DNA
sequencing of isolated library plasmid inserts and the bait
construct was performed on a 373 Sequencer (Applied
Biosystems) at the Columbia University Cancer Center DNA
Core Facility. Sequence analysis was performed using appli-
cations available via the Internet at the National Center for
Biotechnology Information World Wide Website (http://
www.ncbi.nlm.nih.gov).
For direct yeast two-hybrid interaction assays, DNAs
encoding full-length Smad1, Smad2, Smad3, Smad4, various
domains of Smad2 and Smad3 and portions of the C-terminal
domain of MAN1 were generated by polymerase chain reac-
tions and cloned into pGBKT7 and pACT2. To generate
Smad1, Smad2 and Smad4 PCR products for cloning, plas-
mids containing the cDNA sequences, kindly provided by
Dr Joan Massague´ (Memorial Sloan-Kettering Cancer
Center), were used as templates. The full-length Smad3
cDNA template for polymerase chain reaction was a positive
pACT2 clone isolated in the two-hybrid screen. MAN1
cDNA (21) was used as template to generate polymerase
chain reaction products encoding parts of the C-terminal
domain. All plasmid constructs were confirmed by DNA
sequencing. Yeast two-hybrid assays were performed accord-
ing to the instructions of the manufacturer (Clontech).
GST precipitation assays
DNAs encoding Smad2, Smad3 and their various domains
were generated by polymerase chain reaction as described
earlier and cloned in-frame into appropriate pGEX plasmids
(Amersham Pharmacia Biotech) to express GST fusion pro-
teins. All constructs were confirmed by DNA sequencing.
GST fusion proteins were expressed in Esherichia coli using
standard methods (58). For in vitro transcription–translation
of the C-terminal tail domain of MAN1, pGBKT7-MAN1-
CT was used in the TNT T7 Coupled Reticulocyte Lysate
System (Promega) containing L-[35S]-methionine (Amersham
Pharmacia Biotech). GST precipitation assays were performed
as described previously (16,17).
Co-immunoprecipitation
Two 150 mm Petri dishes of 90% confluent HeLa cells were
washed three times with phosphate-buffered saline and then
scraped and collected in a buffer of 10 mM HEPES (pH 7.4),
1 mM dithiothreitol, 0.2 mM phenylmethylsulfonyl fluoride
and 1 mM MgCl2. Cells were placed on ice for 15 min and
Figure 7. Schematic diagram showing how MAN1 may inhibit Smad2 and
Smad3 function within the nucleus. MAN1 binds Smad2 and Smad3 and
may compete with their binding to regulatory regions of Smad2/3-activated
genes. Other factors are also necessary for transcriptional regulation of these
genes. Inactivating mutations in MAN1 have been shown to result in osteopoi-
kilosis, Buschke–Ollendorff syndrome and melorheostosis (24). As MAN1
may be part of an interconnected network of MAN1, lamins and emerin at
the inner nuclear membrane, mutations in emerin and lamins may also lead
to alterations in MAN1 localization and its interactions with Smad2 and
Smad3 in different tissues, such as striated muscle, and this could potentially
play a role in diseases such as Emery–Dreifuss muscular dystrophy.
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broken in a Dounce homogenizer. Broken cells were then cen-
trifuged at 6000g for 20 min at 48C in a J2-21M centrifuge
(Beckman) with a J-20 rotor. The pellet was resuspended in
400 ml buffer containing 50 mM 4-2-hydroxyethyl-1-piperazi-
neethanesulfonic acid (pH 8.0), 5 mM ethylenediaminetetraace-
tic acid, 0.2% bovine serum albumin, 1 mM dithiothreitol,
0.2 mM phenylmethylsulfonyl fluoride and 0.1% Nonident
P-40. Cells were then sonicated with a tip sonicator and centri-
fuged at 48C for 30 min at 13 000 rpm in a 5415D microcentri-
fuge (Eppendorf). The preparation was then incubated with
antibody-coupled protein-A beads prepared according to the
protocol provided with the Seize X Immunoprecipitation Kit
(Pierce Biotechnology). Antibodies in human MAN antiserum
(kindly provided by Dr Micheline Paulin-Levasseur) (21,25)
or control human serum from a subject with primary biliary cir-
rhosis (27) were coupled to beads, and immmunoprecipitation
was performed according to the Seize X Immunoprecipitation
Kit protocol. Proteins were eluted from the beads by
boiling in denaturing SDS sample buffer, separated by SDS–
polyacrylamide gel electrophoresis and analyzed by immuno-
blotting with diluted MAN antiserum, rabbit anti-Smad2
antibodies (Zymed Biotechnology) and rabbit anti-b-tubulin
antibodies (Santa Cruz Biotechnology).
Transcription-response assays
Transcriptional-response assays were performed essentially as
described by Tanaka et al. (59) except that LipofectAmine
(Gibco BRL) was used instead of a calcium phosphate for
cell transfection. HepG2 or Mv1Lu cells were seeded at a
density of 10 000 per 60 mm plate and co-transfected 24 h
later with 2 mg of the reporter plasmid p3TP-LUX (kindly pro-
vided by Dr Joan Massague´), 2 mg of pSV-b-galactosidase
plasmid (Promega) and 2 mg of plasmids encoding MAN1,
its N-terminal domain or its C-terminal domain (21,41).
Endogenous MAN1 was detected in HepG2 cells by immuno-
blotting using MAN antiserum. Expression of proteins
encoded by transfected plasmids was confirmed by immuno-
fluorescence microscopy using anti-FLAG antibodies
(Sigma). Immunofluorescence microscopy was performed
using a Zeiss LSM 410 confocal laser scanning system
attached to a Zeiss Axiovert 100TV inverted microscope
(Carl Zeiss, Inc.) as described previously (21,41). Images
were processed using PhotoShop software (Adobe Systems)
on a Macintosh G3 computer (Apple Computer). Cells were
treated with TGF-b1 (Sigma) for 24 h, and the relative lucifer-
ase activities in cell extracts were measured using a lumin-
ometer (Monolight 2010) and the Luciferase Assay System
(Promega). To correct for differences in transfection efficiency
between experiments, luciferase activities were normalized to
b-galactosidase activities.
Cell proliferation assay
Full-length MAN1 cDNA with a FLAG epitope tag coding
region at the N-terminal (21) was cloned into pcDNA3.1-
myc-His(2)B (Invitrogen). This plasmid was used to establish
stable transfected Mv1Lu cell lines, which expressed
full-length MAN1 with myc, histidine and FLAG epitope
tags. Expressed protein was detected by immunofluorescence
microscopy with anti-FLAG antibodies as described earlier.
CellTiter 96 AQueous One Solution Cell Proliferation Assay
(Promega) was used to determine the number of viable cells.
Cells were seeded in 96 well plates with approximately
5000 cells in 100 ml of medium and incubated with TGF-b1
at serial 2-fold dilutions. After 48 h of incubation, 20 ml of
CellTiter 96 AQueous One Solution reagent was added per
well and incubated for 2 h. Absorbance at 490 nm was then
measured using a 96-well plate reader.
Materials
Unless otherwise indicated, routine chemical reagents were
purchased from Sigma or Fisher. Enzymes for molecular
biology were obtained from New England Biolabs, Invitrogen
or Fisher.
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